|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
British Columbia Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing British ColumbiaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
iCo Therapeutics Inc.
| | | Phone: | (778) 802-9806 | Year Established: | 2005 | Ticker: | ICO | Exchange: | TSX | Main Contact: | Andrew J. Rae, MBA, President, CEO & Director | | Other Contacts: | Peter Hnik, Ph.D., CMO Mike Liggett, CFO
| | Company Description | iCo Therapeutics is a biotechnology company focused on development instead of research. iCo's business model aims to acquire the rights to drugs that are either off-patent, currently approved or near commercialization and develop them by redosing or reformulating them for new or expanded labels. | |
|
|
|
|
|